Clinical Trials List
Protocol Number96-1017A
2008-08-01 - 2011-07-31
Phase II
Terminated1
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shu-Hang Ag Division of Radiology
- Tzu-Chen Yen Division of Nuclear Medicine
- Cheng-Lung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
300 participants
-
Global
0 participants
